Céfoxitine et BLSE [Cefoxitin and ESBL]

Détails

ID Serval
serval:BIB_F813C8E8ED2B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Céfoxitine et BLSE [Cefoxitin and ESBL]
Périodique
Medecine et maladies infectieuses
Auteur⸱e⸱s
Boyer M., Bignon A., Dessein R., Faure K., Guery B., Kipnis E.
ISSN
1769-6690 (Electronic)
ISSN-L
0399-077X
Statut éditorial
Publié
Date de publication
03/2012
Peer-reviewed
Oui
Volume
42
Numéro
3
Pages
126-128
Langue
français
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Mots-clé
Aged, Anti-Bacterial Agents/pharmacology, Anti-Bacterial Agents/therapeutic use, Bacteremia/drug therapy, Bacteremia/microbiology, Bacterial Proteins/genetics, Bacterial Proteins/metabolism, Catheter-Related Infections/complications, Catheter-Related Infections/drug therapy, Catheter-Related Infections/microbiology, Cefoxitin/pharmacology, Cefoxitin/therapeutic use, Cross Infection/drug therapy, Cross Infection/microbiology, Diarrhea/complications, Diarrhea/microbiology, Drug Resistance, Multiple, Bacterial/genetics, Drug Therapy, Combination, Enterococcus faecalis/drug effects, Glycopeptides/pharmacology, Humans, Klebsiella Infections/complications, Klebsiella Infections/drug therapy, Klebsiella Infections/microbiology, Klebsiella pneumoniae/drug effects, Klebsiella pneumoniae/enzymology, Klebsiella pneumoniae/genetics, Klebsiella pneumoniae/isolation & purification, Male, Pancreatic Neoplasms/surgery, Pneumonia, Bacterial/complications, Pneumonia, Bacterial/drug therapy, Pneumonia, Bacterial/microbiology, Postoperative Complications/drug therapy, Postoperative Complications/microbiology, Prostatitis/complications, Prostatitis/drug therapy, Prostatitis/microbiology, Substrate Specificity, Urinary Catheterization/adverse effects, beta-Lactam Resistance, beta-Lactamases/genetics, beta-Lactamases/metabolism
Pubmed
Web of science
Création de la notice
29/04/2021 10:59
Dernière modification de la notice
17/07/2023 13:05
Données d'usage